《大行报告》高盛重申友邦(01299.HK)确信买入 目标价91元不变
高盛发表研究报告指友邦保险(01299.HK)受惠中国及其他市场业务强劲增长,及香港表现具韧性,去年新业务价值录41.54亿美元,以固定汇率计按年升6%,大致符合该行及市场预期。撇除香港,新业务价值按年增16%。
整体而言,报告指友邦去年业务强劲,未显示受到债券收益率下滑带来重大影响。不过,高盛称,考虑中国内地及香港具挑战环境的销售展望,债券收益率下滑料成为友邦今年一个重要主题。高盛重申友邦「买入」评级,并列入「确信买入」名单,目标价91元不变。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.